![](/img/cover-not-exists.png)
7 Outcomes of women with early stage HER-2 over-expressing breast cancer receiving adjuvant trastuzumab: a population based analysis
S. Chia, C. Speers, K. Gelmon, S. Ellard, R. Pickering, S. O'Reilly, M. SealVolume:
8
Year:
2010
Language:
english
DOI:
10.1016/s1359-6349(10)70039-2
File:
PDF, 64 KB
english, 2010